Kwality Pharmaceuticals Ltd (KPL) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1002639,
    "name": "Kwality Pharma",
    "stock_name": "Kwality Pharma",
    "full_name": "Kwality Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/kwality-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,399.00",
    "chg": 38.2,
    "chgp": "1.62%",
    "dir": 1,
    "prev_price": "2,360.80",
    "mcapval": "2,439.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 539997,
    "symbol": "KPL",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE552U01010",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "40.7 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/kwality-pharma-1002639-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Are Kwality Pharmaceuticals Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-kwality-pharmaceuticals-ltd-latest-results-good-or-bad-4001502",
        "imagepath": "",
        "date": "2026-05-20 19:23:10",
        "description": "Kwality Pharmaceuticals Ltd reported its financial results for Q4 FY26, showcasing notable operational trends. The company achieved a net profit of ₹25.30 crores, reflecting a year-on-year growth of 74.60% and a quarter-on-quarter increase of 58.03%. Revenue for the same period reached ₹157.11 crores, marking a year-on-year growth of 35.81% and a sequential rise of 27.28%. This revenue performance indicates a robust operational trajectory, as it represents the strongest quarterly topline in recent history.\n\nThe operating margin for Q4 FY26 was recorded at 24.66%, which is the highest quarterly margin on record for the company, demonstrating effective cost management and operational efficiency. Additionally, the profit before tax reached ₹30.61 crores, also the highest quarterly figure, with a significant improvement in the PAT margin to 16.11%, up from 12.52% in the previous year.\n\nKwality Pharmaceuticals m..."
      },
      {
        "title": "Kwality Pharmaceuticals Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kwality-pharmaceuticals-ltd-is-rated-buy-4000678",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/KwalityPharmace_mojoScore_4000678.png",
        "date": "2026-05-20 10:10:56",
        "description": "Kwality Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Kwality Pharmaceuticals Ltd to 52-Week High of Rs 2194.4",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kwality-pharmaceuticals-ltd-hits-new-52-week-high-at-rs21944-4000523",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/KwalityPharmace_priceRelatedfactors_4000523.png",
        "date": "2026-05-20 09:40:27",
        "description": "From a 52-week low of Rs 810.5 to a fresh high of Rs 2194.4 on 20 May 2026, Kwality Pharmaceuticals Ltd has more than doubled in value over the past year, delivering a remarkable 123.07% return. This surge comes amid a backdrop of mixed market conditions, with the Sensex trading below its 50-day moving average and hovering near its own 52-week low."
      },
      {
        "title": "Kwality Pharmaceuticals Ltd Hits All-Time High of Rs 2,194.4 as Momentum Builds Across Timeframes",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kwality-pharmaceuticals-ltd-hits-record-high-of-rs-219440-on-20-may-2026-4000490",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/KwalityPharmace_priceRelatedfactors_4000490.png",
        "date": "2026-05-20 09:32:28",
        "description": ""
      },
      {
        "title": "Kwality Pharmaceuticals Ltd Reports Very Positive Quarterly Financial Performance Amid Strong Market Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kwality-pharmaceuticals-ltd-reports-very-positive-quarterly-financial-performance-amid-strong-market-returns-3999993",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/KwalityPharmace_fintrenddot_3999993.png",
        "date": "2026-05-20 08:00:20",
        "description": "Kwality Pharmaceuticals Ltd has demonstrated a marked improvement in its financial performance for the quarter ended March 2026, shifting from an outstanding to a very positive financial trend. This robust quarterly showing is complemented by impressive stock returns that have significantly outpaced the broader Sensex index over multiple time horizons."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Kwality Pharmaceuticals Ltd to 52-Week High of Rs 1920",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kwality-pharmaceuticals-ltd-hits-new-52-week-high-at-rs1920-3998584",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/KwalityPharmace_priceRelatedfactors_3998584.png",
        "date": "2026-05-19 09:40:42",
        "description": "Surging to an intraday peak of Rs 1920 on 19 May 2026, Kwality Pharmaceuticals Ltd has marked a significant milestone by hitting a new 52-week and all-time high. This rally, driven by a confluence of robust technical signals and sustained price momentum, underscores the stock’s impressive performance over the past year, outpacing the broader market by a wide margin."
      },
      {
        "title": "Kwality Pharmaceuticals Ltd Hits All-Time High of Rs 1891.4 as Momentum Builds Across Timeframes",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kwality-pharmaceuticals-ltd-hits-all-time-high-at-rs-18914-3998548",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/KwalityPharmace_priceRelatedfactors_3998548.png",
        "date": "2026-05-19 09:32:59",
        "description": "Extending its winning streak to five consecutive sessions, Kwality Pharmaceuticals Ltd surged to a fresh all-time high of Rs 1891.4 on 19 May 2026, outperforming its sector and the broader market with notable volatility and strong volume support."
      },
      {
        "title": "Kwality Pharmaceuticals Ltd Valuation Shifts Signal Heightened Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kwality-pharmaceuticals-ltd-valuation-shifts-signal-heightened-price-attractiveness-3997867",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/KwalityPharmace_valuationdot_3997867.png",
        "date": "2026-05-19 08:02:16",
        "description": "Kwality Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a very expensive category, reflecting a significant change in price attractiveness. This transition, coupled with robust financial metrics and strong market performance, positions the micro-cap pharmaceutical firm as a compelling buy in the current market environment."
      },
      {
        "title": "Kwality Pharmaceuticals Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kwality-pharmaceuticals-ltd-is-rated-buy-3982841",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/KwalityPharmace_mojoScore_3982841.png",
        "date": "2026-05-09 10:10:14",
        "description": "Kwality Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 Jan 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 09 May 2026, providing investors with the latest insights into its performance and outlook."
      }
    ],
    "total": 15,
    "sid": "1002639",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/kwality-pharmaceuticals-1002639"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Resignation of Director",
      "datetime": "02-Jun-2026",
      "details": "Resignation of Mr. Kartik Kapur Independent Director of the Company.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "02-Jun-2026",
      "details": "Appointment of Mr. Swanith Kapoor as Additional (Non-Executive Independent) Director and Resignation of Mr. Kartik Kapur Independent Director of the Company.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "30-May-2026",
      "details": "Annual Secretarial Compliance Report for the year ended 31-03-2026 is enclosed herewith",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Kwality Pharmaceuticals Ltd has declared <strong>6%</strong> dividend, ex-date: 05 Jan 17",
          "dt": "2017-01-05",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Kwality Pharmaceuticals Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 11 Oct 17",
          "dt": "2017-10-11",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Are Kwality Pharmaceuticals Ltd latest results good or bad?

2026-05-20 19:23:10

Kwality Pharmaceuticals Ltd reported its financial results for Q4 FY26, showcasing notable operational trends. The company achieved a net profit of ₹25.30 crores, reflecting a year-on-year growth of 74.60% and a quarter-on-quarter increase of 58.03%. Revenue for the same period reached ₹157.11 crores, marking a year-on-year growth of 35.81% and a sequential rise of 27.28%. This revenue performance indicates a robust operational trajectory, as it represents the strongest quarterly topline in recent history. The operating margin for Q4 FY26 was recorded at 24.66%, which is the highest quarterly margin on record for the company, demonstrating effective cost management and operational efficiency. Additionally, the profit before tax reached ₹30.61 crores, also the highest quarterly figure, with a significant improvement in the PAT margin to 16.11%, up from 12.52% in the previous year. Kwality Pharmaceuticals m...

Kwality Pharmaceuticals Ltd is Rated Buy

2026-05-20 10:10:56

Kwality Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Broad-Based Technical Strength Lifts Kwality Pharmaceuticals Ltd to 52-Week High of Rs 2194.4

2026-05-20 09:40:27

From a 52-week low of Rs 810.5 to a fresh high of Rs 2194.4 on 20 May 2026, Kwality Pharmaceuticals Ltd has more than doubled in value over the past year, delivering a remarkable 123.07% return. This surge comes amid a backdrop of mixed market conditions, with the Sensex trading below its 50-day moving average and hovering near its own 52-week low.

Kwality Pharmaceuticals Ltd Hits All-Time High of Rs 2,194.4 as Momentum Builds Across Timeframes

2026-05-20 09:32:28

Kwality Pharmaceuticals Ltd Reports Very Positive Quarterly Financial Performance Amid Strong Market Returns

2026-05-20 08:00:20

Kwality Pharmaceuticals Ltd has demonstrated a marked improvement in its financial performance for the quarter ended March 2026, shifting from an outstanding to a very positive financial trend. This robust quarterly showing is complemented by impressive stock returns that have significantly outpaced the broader Sensex index over multiple time horizons.

Broad-Based Technical Strength Lifts Kwality Pharmaceuticals Ltd to 52-Week High of Rs 1920

2026-05-19 09:40:42

Surging to an intraday peak of Rs 1920 on 19 May 2026, Kwality Pharmaceuticals Ltd has marked a significant milestone by hitting a new 52-week and all-time high. This rally, driven by a confluence of robust technical signals and sustained price momentum, underscores the stock’s impressive performance over the past year, outpacing the broader market by a wide margin.

Kwality Pharmaceuticals Ltd Hits All-Time High of Rs 1891.4 as Momentum Builds Across Timeframes

2026-05-19 09:32:59

Extending its winning streak to five consecutive sessions, Kwality Pharmaceuticals Ltd surged to a fresh all-time high of Rs 1891.4 on 19 May 2026, outperforming its sector and the broader market with notable volatility and strong volume support.

Kwality Pharmaceuticals Ltd Valuation Shifts Signal Heightened Price Attractiveness

2026-05-19 08:02:16

Kwality Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a very expensive category, reflecting a significant change in price attractiveness. This transition, coupled with robust financial metrics and strong market performance, positions the micro-cap pharmaceutical firm as a compelling buy in the current market environment.

Kwality Pharmaceuticals Ltd is Rated Buy

2026-05-09 10:10:14

Kwality Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 Jan 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 09 May 2026, providing investors with the latest insights into its performance and outlook.

View All News